Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-04-18 00:00:00 ET · period of report 2022-04-14 · accession 0001567619-22-008633 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-18 | 2022-04-14 | BMRN | LAWLIS V BRYAN | Dir | S - Sale+OE | $83.66 | -4,250 | 24.0K | -15% | -$355.6K |
| D | 2022-04-18 | 2022-04-14 | BMRN | LAWLIS V BRYAN | Dir | M - OptEx | $37.46 | +4,250 | 28.2K | +18% | +$159.2K |
| D | 2022-04-18 | 2022-04-14 | BMRN | LAWLIS V BRYAN | Dir | M - OptEx | $0.00 | -4,250 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | S | D | 4,250 | $83.66 | 23,970 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on July 29, 2021. |
| 2 | Common | Common Stock | 2022-04-14 | M | A | 4,250 | $37.46 | 28,220 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on July 29, 2021. |
| 3 | Derivative | Stock Option (Right to buy Common Stock) | 2022-04-14 | M | D | 4,250 | $0.00 | 0 | D | $37.46 · 2012-11-08 to 2022-05-07 | 4,250 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on July 29, 2021. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |